stem cell therapy (Daewoong)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug Namestem cell therapy (Daewoong)
Drug Alias NameN/A
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy
Mechanisms of ActionStem cells modulators
TargetsUpdating
Therapy Area/IndicationsDiabetes MellitusArthritis, Rheumatoid
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesDaewoong Pharmaceutical Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesDaewoong Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsDiabetes MellitusArthritis, Rheumatoid

Other Information

ATC CodeN/A
Related LinksN/A